data_2oi3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2oi3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.07 159.13 53.26 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.689 2.926 . . . . 0.0 113.342 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.4 161.68 30.04 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.43 1.492 . . . . 0.0 112.83 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.12 163.56 33.73 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.682 1.134 . . . . 0.0 113.479 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.1 p -78.66 162.02 67.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.039 1.336 . . . . 0.0 113.129 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.59 156.03 9.32 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.962 3.108 . . . . 0.0 114.201 168.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.69 89.4 0.1 OUTLIER Glycine 0 N--CA 1.469 0.884 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.676 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.96 165.71 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.778 2.318 . . . . 0.0 113.184 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -73.61 -2.15 21.79 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.1 p -148.8 166.54 28.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.561 1.545 . . . . 0.0 112.427 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -148.2 147.39 29.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.639 1.176 . . . . 0.0 111.919 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -156.8 162.38 39.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.135 1.774 . . . . 0.0 111.086 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.8 m -160.18 153.64 22.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.823 1.249 . . . . 0.0 112.238 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -156.08 169.31 24.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.544 1.938 . . . . 0.0 109.368 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.0 p -62.75 147.43 93.3 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.123 -0.986 . . . . 0.0 112.553 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.54 -170.87 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.984 3.122 . . . . 0.0 112.554 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.46 40.55 0.92 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 125.956 1.741 . . . . 0.0 116.053 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.44 129.92 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.964 1.706 . . . . 0.0 110.869 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -76.24 175.78 8.72 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -147.28 170.08 18.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.65 2.38 . . . . 0.0 111.363 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.81 -167.68 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.399 1.88 . . . . 0.0 115.481 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.56 -21.18 0.07 OUTLIER Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.877 1.111 . . . . 0.0 115.877 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.8 m -49.01 -30.58 6.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -138.12 30.1 2.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.558 1.543 . . . . 0.0 113.178 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -143.06 88.3 2.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.787 2.835 . . . . 0.0 107.553 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 mm -71.61 84.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.377 1.071 . . . . 0.0 109.485 -175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.3 mm -69.32 108.49 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.11 170.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 125.493 1.517 . . . . 0.0 108.158 163.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 127.72 2.408 . . . . 0.0 108.949 166.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.56 122.72 18.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.236 1.015 . . . . 0.0 110.731 167.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.4 -36.19 76.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.146 1.378 . . . . 0.0 111.723 168.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' B' ' 97' ' ' PRO . 4.0 m-85 -141.07 160.98 38.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.277 1.431 . . . . 0.0 112.545 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.83 134.76 45.01 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.643 0.777 . . . . 0.0 112.534 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.95 138.4 42.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.721 1.208 . . . . 0.0 113.211 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -138.33 62.78 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.427 -0.796 . . . . 0.0 112.529 -171.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 27.28 75.6 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.795 2.438 . . . . 0.0 115.824 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.82 -35.57 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.593 1.157 . . . . 0.0 112.107 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -137.26 173.36 11.77 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.194 2.198 . . . . 0.0 110.373 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -67.31 160.66 26.71 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 50.57 55.41 9.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.128 1.771 . . . . 0.0 113.541 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' CG ' ' HZ2' ' B' ' 90' ' ' LYS . 44.9 m-20 -137.9 148.27 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.845 1.307 . . . . 0.0 108.857 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.34 148.54 51.52 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.284 -1.78 . . . . 0.0 109.685 166.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 m -112.36 115.89 29.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 108.442 162.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -122.25 175.93 6.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.152 1.781 . . . . 0.0 111.643 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -124.91 155.82 38.94 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 120.767 -1.208 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -52.98 122.01 8.48 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.567 0.747 . . . . 0.0 109.816 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 6.83 78.66 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.14 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.51 114.28 8.47 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 161.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -73.99 147.67 42.77 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.46 1.124 . . . . 0.0 110.076 161.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 64' ' ' SER . 32.9 mtm -141.54 134.58 29.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.391 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.98 103.64 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 167.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.71 139.15 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.21 1.004 . . . . 0.0 109.842 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.41 -38.69 2.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.328 2.251 . . . . 0.0 111.385 -170.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -132.33 142.17 49.24 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.094 0.558 . . . . 0.0 111.539 167.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -145.27 91.08 2.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.164 2.185 . . . . 0.0 107.206 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -146.22 21.63 1.37 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.339 1.055 . . . . 0.0 113.273 -171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.92 45.91 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.258 1.409 . . . . 0.0 110.87 -169.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -73.96 -12.89 60.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.4 137.76 54.13 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.964 1.306 . . . . 0.0 110.216 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -120.32 139.23 53.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.893 1.277 . . . . 0.0 110.192 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -72.19 135.24 46.06 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 0.0 108.161 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.22 167.83 24.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.437 1.017 . . . . 0.0 113.053 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -126.47 122.39 35.08 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.272 1.429 . . . . 0.0 111.134 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 73.3 m -49.39 106.36 0.11 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 126.513 1.925 . . . . 0.0 111.089 167.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -10.56 59.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.192 1.797 . . . . 0.0 110.997 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.66 -21.99 22.49 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -140.32 -4.86 1.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . 0.314 38.2 ptt180 52.04 32.31 10.08 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 129.125 2.97 . . . . 0.0 115.249 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.36 152.22 30.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.039 1.735 . . . . 0.0 109.828 165.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -136.42 153.81 50.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.789 1.177 . . . . 0.0 112.911 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.49 171.02 34.7 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.688 1.137 . . . . 0.0 113.668 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 152.79 43.38 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.317 1.058 . . . . 0.0 110.97 162.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.0 pt -145.73 153.85 51.11 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.057 0.943 . . . . 0.0 111.69 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.8 122.23 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.276 3.317 . . . . 0.0 112.388 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.5 p -65.61 -25.91 67.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -66.64 -21.24 66.12 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.082 -1.012 . . . . 0.0 113.247 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.92 9.95 30.84 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.497 1.919 . . . . 0.0 113.755 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.42 162.71 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.532 0.682 . . . . 0.0 111.412 -152.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.17 131.85 1.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.348 -165.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.87 134.52 51.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.531 1.132 . . . . 0.0 111.906 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -32.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-O 121.934 0.873 . . . . 0.0 112.255 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.0 -12.03 61.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.84 2.056 . . . . 0.0 114.616 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -121.14 12.62 11.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.801 1.24 . . . . 0.0 113.87 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.5 mt -78.08 168.78 19.34 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.103 1.361 . . . . 0.0 112.447 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.71 35.02 3.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 111.315 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.62 1.968 . . . . 0.0 111.922 -170.848 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.016 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -142.68 168.15 20.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.702 1.601 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -139.61 43.56 1.98 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.361 1.553 . . . . 0.0 110.422 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.477 ' HZ2' ' CG ' ' A' ' 41' ' ' ASP . 16.6 ptmt -52.82 -28.32 22.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.918 2.487 . . . . 0.0 115.418 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -150.52 154.57 35.66 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 127.148 2.179 . . . . 0.0 109.026 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.33 49.71 2.69 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.981 3.787 . . . . 0.0 113.306 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 30.2 mt 59.61 154.04 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 129.997 3.319 . . . . 0.0 115.711 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.57 158.51 56.96 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.876 3.051 . . . . 0.0 112.869 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.33 115.42 4.3 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.953 2.435 . . . . 0.0 110.057 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 23.2 mt -53.89 155.56 5.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.853 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 32' ' ' TYR . 1.1 Cg_endo -72.01 179.72 4.63 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.44 2.76 . . . . 0.0 112.999 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 86.4 p -66.62 -18.82 65.57 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.009 1.324 . . . . 0.0 114.486 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.15 22.01 4.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.86 2.064 . . . . 0.0 114.348 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 O-C-N 119.95 -1.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.07 159.13 53.26 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.689 2.926 . . . . 0.0 113.342 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.4 161.68 30.04 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.43 1.492 . . . . 0.0 112.83 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.12 163.56 33.73 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.682 1.134 . . . . 0.0 113.479 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.1 p -78.66 162.02 67.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.039 1.336 . . . . 0.0 113.129 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.59 156.03 9.32 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.962 3.108 . . . . 0.0 114.201 168.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.69 89.4 0.1 OUTLIER Glycine 0 N--CA 1.469 0.884 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.676 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.96 165.71 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.778 2.318 . . . . 0.0 113.184 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -73.61 -2.15 21.79 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.1 p -148.8 166.54 28.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.561 1.545 . . . . 0.0 112.427 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -148.2 147.39 29.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.639 1.176 . . . . 0.0 111.919 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -156.8 162.38 39.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.135 1.774 . . . . 0.0 111.086 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.8 m -160.18 153.64 22.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.823 1.249 . . . . 0.0 112.238 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -156.08 169.31 24.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.544 1.938 . . . . 0.0 109.368 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.0 p -62.75 147.43 93.3 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.123 -0.986 . . . . 0.0 112.553 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.54 -170.87 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.984 3.122 . . . . 0.0 112.554 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.46 40.55 0.92 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 125.956 1.741 . . . . 0.0 116.053 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.44 129.92 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.964 1.706 . . . . 0.0 110.869 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -76.24 175.78 8.72 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -147.28 170.08 18.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.65 2.38 . . . . 0.0 111.363 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.81 -167.68 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.399 1.88 . . . . 0.0 115.481 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.56 -21.18 0.07 OUTLIER Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.877 1.111 . . . . 0.0 115.877 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.8 m -49.01 -30.58 6.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -138.12 30.1 2.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.558 1.543 . . . . 0.0 113.178 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -143.06 88.3 2.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.787 2.835 . . . . 0.0 107.553 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 6.1 mm -71.61 84.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.377 1.071 . . . . 0.0 109.485 -175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.3 mm -69.32 108.49 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.445 HG22 ' C ' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -100.11 170.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 125.493 1.517 . . . . 0.0 108.158 163.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 127.72 2.408 . . . . 0.0 108.949 166.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.56 122.72 18.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.236 1.015 . . . . 0.0 110.731 167.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.4 -36.19 76.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.146 1.378 . . . . 0.0 111.723 168.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CE2' HD22 ' B' ' 96' ' ' LEU . 4.0 m-85 -141.07 160.98 38.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.277 1.431 . . . . 0.0 112.545 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.83 134.76 45.01 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.643 0.777 . . . . 0.0 112.534 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.95 138.4 42.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.721 1.208 . . . . 0.0 113.211 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -138.33 62.78 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.427 -0.796 . . . . 0.0 112.529 -171.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 27.28 75.6 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.795 2.438 . . . . 0.0 115.824 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.82 -35.57 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.593 1.157 . . . . 0.0 112.107 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -137.26 173.36 11.77 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.194 2.198 . . . . 0.0 110.373 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -67.31 160.66 26.71 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 50.57 55.41 9.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.128 1.771 . . . . 0.0 113.541 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -137.9 148.27 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.845 1.307 . . . . 0.0 108.857 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.34 148.54 51.52 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.284 -1.78 . . . . 0.0 109.685 166.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 m -112.36 115.89 29.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 108.442 162.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -122.25 175.93 6.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.152 1.781 . . . . 0.0 111.643 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -124.91 155.82 38.94 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 120.767 -1.208 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -52.98 122.01 8.48 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.567 0.747 . . . . 0.0 109.816 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 6.83 78.66 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.14 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.51 114.28 8.47 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 161.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -73.99 147.67 42.77 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.46 1.124 . . . . 0.0 110.076 161.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 64' ' ' SER . 32.9 mtm -141.54 134.58 29.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.391 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.98 103.64 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 167.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 25.3 t -65.71 139.15 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.21 1.004 . . . . 0.0 109.842 167.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.41 -38.69 2.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.328 2.251 . . . . 0.0 111.385 -170.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -132.33 142.17 49.24 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.094 0.558 . . . . 0.0 111.539 167.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -145.27 91.08 2.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.164 2.185 . . . . 0.0 107.206 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -146.22 21.63 1.37 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.339 1.055 . . . . 0.0 113.273 -171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.92 45.91 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.258 1.409 . . . . 0.0 110.87 -169.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -73.96 -12.89 60.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.4 137.76 54.13 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.964 1.306 . . . . 0.0 110.216 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -120.32 139.23 53.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.893 1.277 . . . . 0.0 110.192 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -72.19 135.24 46.06 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 0.0 108.161 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.22 167.83 24.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.437 1.017 . . . . 0.0 113.053 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -126.47 122.39 35.08 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.272 1.429 . . . . 0.0 111.134 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 73.3 m -49.39 106.36 0.11 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 126.513 1.925 . . . . 0.0 111.089 167.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -10.56 59.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.192 1.797 . . . . 0.0 110.997 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.66 -21.99 22.49 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -140.32 -4.86 1.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . 0.314 38.2 ptt180 52.04 32.31 10.08 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 129.125 2.97 . . . . 0.0 115.249 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.36 152.22 30.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.039 1.735 . . . . 0.0 109.828 165.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -136.42 153.81 50.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.789 1.177 . . . . 0.0 112.911 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.49 171.02 34.7 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.688 1.137 . . . . 0.0 113.668 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 152.79 43.38 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.317 1.058 . . . . 0.0 110.97 162.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.0 pt -145.73 153.85 51.11 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.057 0.943 . . . . 0.0 111.69 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.8 122.23 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.276 3.317 . . . . 0.0 112.388 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.5 p -65.61 -25.91 67.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.615 ' HB3' HD13 ' B' ' 93' ' ' LEU . 10.7 p-10 -66.64 -21.24 66.12 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.082 -1.012 . . . . 0.0 113.247 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.92 9.95 30.84 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.497 1.919 . . . . 0.0 113.755 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.42 162.71 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.532 0.682 . . . . 0.0 111.412 -152.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -167.17 131.85 1.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.348 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.87 134.52 51.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.531 1.132 . . . . 0.0 111.906 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -32.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-O 121.934 0.873 . . . . 0.0 112.255 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.0 -12.03 61.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.84 2.056 . . . . 0.0 114.616 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -121.14 12.62 11.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.801 1.24 . . . . 0.0 113.87 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.5 mt -78.08 168.78 19.34 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.103 1.361 . . . . 0.0 112.447 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.71 35.02 3.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 111.315 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.62 1.968 . . . . 0.0 111.922 -170.848 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.016 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -142.68 168.15 20.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.702 1.601 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -139.61 43.56 1.98 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.361 1.553 . . . . 0.0 110.422 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -52.82 -28.32 22.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.918 2.487 . . . . 0.0 115.418 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -150.52 154.57 35.66 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 127.148 2.179 . . . . 0.0 109.026 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.33 49.71 2.69 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.981 3.787 . . . . 0.0 113.306 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 76' ' ' ASN . 30.2 mt 59.61 154.04 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 129.997 3.319 . . . . 0.0 115.711 -170.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.57 158.51 56.96 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.876 3.051 . . . . 0.0 112.869 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.33 115.42 4.3 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.953 2.435 . . . . 0.0 110.057 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 32' ' ' TYR . 23.2 mt -53.89 155.56 5.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.853 174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.01 179.72 4.63 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.44 2.76 . . . . 0.0 112.999 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 86.4 p -66.62 -18.82 65.57 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.009 1.324 . . . . 0.0 114.486 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.15 22.01 4.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.86 2.064 . . . . 0.0 114.348 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 O-C-N 119.95 -1.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.07 159.13 53.26 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.689 2.926 . . . . 0.0 113.342 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.4 161.68 30.04 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.43 1.492 . . . . 0.0 112.83 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.12 163.56 33.73 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.682 1.134 . . . . 0.0 113.479 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.1 p -78.66 162.02 67.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.039 1.336 . . . . 0.0 113.129 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.59 156.03 9.32 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.962 3.108 . . . . 0.0 114.201 168.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.69 89.4 0.1 OUTLIER Glycine 0 N--CA 1.469 0.884 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.676 -175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.96 165.71 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.778 2.318 . . . . 0.0 113.184 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -73.61 -2.15 21.79 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.1 p -148.8 166.54 28.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.561 1.545 . . . . 0.0 112.427 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -148.2 147.39 29.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.639 1.176 . . . . 0.0 111.919 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -156.8 162.38 39.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.135 1.774 . . . . 0.0 111.086 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.8 m -160.18 153.64 22.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.823 1.249 . . . . 0.0 112.238 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -156.08 169.31 24.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.544 1.938 . . . . 0.0 109.368 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.0 p -62.75 147.43 93.3 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 121.123 -0.986 . . . . 0.0 112.553 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.54 -170.87 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.984 3.122 . . . . 0.0 112.554 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.46 40.55 0.92 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 125.956 1.741 . . . . 0.0 116.053 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.44 129.92 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.964 1.706 . . . . 0.0 110.869 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -76.24 175.78 8.72 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -147.28 170.08 18.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.65 2.38 . . . . 0.0 111.363 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.81 -167.68 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.399 1.88 . . . . 0.0 115.481 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.56 -21.18 0.07 OUTLIER Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.877 1.111 . . . . 0.0 115.877 -173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.8 m -49.01 -30.58 6.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -138.12 30.1 2.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.558 1.543 . . . . 0.0 113.178 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -143.06 88.3 2.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.787 2.835 . . . . 0.0 107.553 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 6.1 mm -71.61 84.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.377 1.071 . . . . 0.0 109.485 -175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.3 mm -69.32 108.49 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.445 HG22 ' C ' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -100.11 170.66 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 125.493 1.517 . . . . 0.0 108.158 163.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.45 144.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 127.72 2.408 . . . . 0.0 108.949 166.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.56 122.72 18.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.236 1.015 . . . . 0.0 110.731 167.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.4 -36.19 76.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.146 1.378 . . . . 0.0 111.723 168.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CE2' HD22 ' B' ' 96' ' ' LEU . 4.0 m-85 -141.07 160.98 38.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.277 1.431 . . . . 0.0 112.545 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.83 134.76 45.01 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.643 0.777 . . . . 0.0 112.534 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.95 138.4 42.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.721 1.208 . . . . 0.0 113.211 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -138.33 62.78 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.427 -0.796 . . . . 0.0 112.529 -171.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 27.28 75.6 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.795 2.438 . . . . 0.0 115.824 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.1 mt -53.82 -35.57 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.593 1.157 . . . . 0.0 112.107 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -137.26 173.36 11.77 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.194 2.198 . . . . 0.0 110.373 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -67.31 160.66 26.71 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 50.57 55.41 9.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.128 1.771 . . . . 0.0 113.541 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -137.9 148.27 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.845 1.307 . . . . 0.0 108.857 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.34 148.54 51.52 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.284 -1.78 . . . . 0.0 109.685 166.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 m -112.36 115.89 29.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 108.442 162.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -122.25 175.93 6.12 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.152 1.781 . . . . 0.0 111.643 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -124.91 155.82 38.94 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 120.767 -1.208 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -52.98 122.01 8.48 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.567 0.747 . . . . 0.0 109.816 175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 6.83 78.66 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.14 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.51 114.28 8.47 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 161.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -73.99 147.67 42.77 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.46 1.124 . . . . 0.0 110.076 161.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 64' ' ' SER . 32.9 mtm -141.54 134.58 29.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.391 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.98 103.64 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 167.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 25.3 t -65.71 139.15 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.21 1.004 . . . . 0.0 109.842 167.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.41 -38.69 2.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.328 2.251 . . . . 0.0 111.385 -170.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -132.33 142.17 49.24 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.094 0.558 . . . . 0.0 111.539 167.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -145.27 91.08 2.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.164 2.185 . . . . 0.0 107.206 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -146.22 21.63 1.37 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.339 1.055 . . . . 0.0 113.273 -171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.92 45.91 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.258 1.409 . . . . 0.0 110.87 -169.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -73.96 -12.89 60.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.4 137.76 54.13 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.964 1.306 . . . . 0.0 110.216 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -120.32 139.23 53.05 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.893 1.277 . . . . 0.0 110.192 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -72.19 135.24 46.06 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 0.0 108.161 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.22 167.83 24.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.437 1.017 . . . . 0.0 113.053 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -126.47 122.39 35.08 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.272 1.429 . . . . 0.0 111.134 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HA ' ' HG2' ' A' ' 50' ' ' MET . 73.3 m -49.39 106.36 0.11 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 126.513 1.925 . . . . 0.0 111.089 167.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -10.56 59.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.192 1.797 . . . . 0.0 110.997 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.66 -21.99 22.49 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -140.32 -4.86 1.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -165.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . 0.314 38.2 ptt180 52.04 32.31 10.08 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 129.125 2.97 . . . . 0.0 115.249 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.36 152.22 30.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.039 1.735 . . . . 0.0 109.828 165.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -136.42 153.81 50.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.789 1.177 . . . . 0.0 112.911 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.49 171.02 34.7 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.688 1.137 . . . . 0.0 113.668 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.8 152.79 43.38 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.317 1.058 . . . . 0.0 110.97 162.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.0 pt -145.73 153.85 51.11 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.057 0.943 . . . . 0.0 111.69 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.8 122.23 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.276 3.317 . . . . 0.0 112.388 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.5 p -65.61 -25.91 67.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.615 ' HB3' HD13 ' B' ' 93' ' ' LEU . 10.7 p-10 -66.64 -21.24 66.12 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.082 -1.012 . . . . 0.0 113.247 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.92 9.95 30.84 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.497 1.919 . . . . 0.0 113.755 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.42 162.71 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.532 0.682 . . . . 0.0 111.412 -152.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -167.17 131.85 1.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.348 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.87 134.52 51.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.531 1.132 . . . . 0.0 111.906 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -58.91 -32.46 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-O 121.934 0.873 . . . . 0.0 112.255 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.0 -12.03 61.32 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.84 2.056 . . . . 0.0 114.616 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -121.14 12.62 11.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.801 1.24 . . . . 0.0 113.87 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.5 mt -78.08 168.78 19.34 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.103 1.361 . . . . 0.0 112.447 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.71 35.02 3.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 111.315 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.62 1.968 . . . . 0.0 111.922 -170.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.016 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -142.68 168.15 20.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.702 1.601 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -139.61 43.56 1.98 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 123.361 1.553 . . . . 0.0 110.422 171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -52.82 -28.32 22.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.918 2.487 . . . . 0.0 115.418 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -150.52 154.57 35.66 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 127.148 2.179 . . . . 0.0 109.026 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.33 49.71 2.69 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.981 3.787 . . . . 0.0 113.306 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 76' ' ' ASN . 30.2 mt 59.61 154.04 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 129.997 3.319 . . . . 0.0 115.711 -170.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.57 158.51 56.96 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.876 3.051 . . . . 0.0 112.869 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.33 115.42 4.3 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.953 2.435 . . . . 0.0 110.057 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 32' ' ' TYR . 23.2 mt -53.89 155.56 5.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.853 174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.01 179.72 4.63 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.44 2.76 . . . . 0.0 112.999 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 86.4 p -66.62 -18.82 65.57 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.009 1.324 . . . . 0.0 114.486 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.15 22.01 4.33 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.86 2.064 . . . . 0.0 114.348 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 O-C-N 119.95 -1.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_